Publication | Closed Access

In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors

Cell TherapyTransplantationMarrow TransplantationMedicineStem Cell TransplantationImmunologyHematologyRelated DonorsAutoimmunityGraft SurvivalPretransplant Anti-thymocyte GlobulinRadiation OncologyImmunotherapyCell TransplantationGraft RejectionHealth Sciences